Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Sight Sciences, a growth-stage medical device company (Nasdaq: SGHT), will participate in the Morgan Stanley Global Healthcare Conference on September 9, 2021, at 9:30 am ET. The event will be accessible via a live and archived webcast on their website. Founded in 2011, Sight Sciences focuses on addressing major eye diseases with innovative products like the OMNI® Surgical System and the TearCare® System. For more details, visit their official website.

News Market Reaction – SGHT

+1.97%

1 alert

+1.97% News Effect

On the day this news was published, SGHT gained 1.97%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on developing and commercializing devices designed to address the underlying causes of the world's most prevalent eye diseases, today announced plans to participate in the upcoming virtual Morgan Stanley Global Healthcare Conference.

Sight Sciences’ management is scheduled to present Thursday, September 9, 2021 at 9:30am ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.sightsciences.com/ .

About Sight Sciences
Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world’s most prevalent eye diseases. The company currently markets two products, the OMNI^® Surgical System and the TearCare^® System. For more information, visit www.sightsciences.com.

Media contact:
Shay Smith
Health+Commerce
707.971.9779
shay@healthandcommerce.com

Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
Investor.Relations@Sightsciences.com

FAQ

When is the Sight Sciences presentation at the Morgan Stanley Global Healthcare Conference?

Sight Sciences is scheduled to present on September 9, 2021, at 9:30 am ET.

How can I access the Sight Sciences conference presentation?

The presentation can be accessed via a live and archived webcast on the Investors section of Sight Sciences’ website.

What products does Sight Sciences develop?

Sight Sciences develops the OMNI® Surgical System and the TearCare® System to address underlying causes of prevalent eye diseases.

What is the stock symbol for Sight Sciences?

The stock symbol for Sight Sciences is SGHT.

When was Sight Sciences founded?

Sight Sciences was founded in 2011.